Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer.

A phase II study was designed to evaluate objective response rate and toxicity of fotemustine as single-drug chemotherapy in non-small-cell lung cancer. Eighty-seven patients with unresectable non-small-cell lung cancer took part in the study. Seventy-seven were evaluable for response. Of these, 60%...

詳細記述

保存先:
書誌詳細
主要な著者: Pujol, J. L., Monnier, A., Berille, J., Cerrina, M. L., Douillard, J. Y., Rivière, A., Grandgirard, A., Gouva, S., Bizzari, J. P., Le Chevalier, T.
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 1994
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC1969429/
https://ncbi.nlm.nih.gov/pubmed/8198982
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料